BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15325704)

  • 1. Current guidelines in defining therapeutic strategies.
    Ferrajoli A; Keating MJ
    Hematol Oncol Clin North Am; 2004 Aug; 18(4):881-93, ix. PubMed ID: 15325704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revision of the guidelines for diagnosis and therapy of chronic lymphocytic leukemia (CLL).
    Eichhorst B; Hallek M
    Best Pract Res Clin Haematol; 2007 Sep; 20(3):469-77. PubMed ID: 17707834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CLL response criteria.
    Cheson BD
    Clin Adv Hematol Oncol; 2006 May; 4(5):4-5; discussion 10; suppl 12. PubMed ID: 16830419
    [No Abstract]   [Full Text] [Related]  

  • 4. Chronic lymphocytic leukemia.
    Ghia P; Ferreri AM; Caligaris-Cappio F
    Crit Rev Oncol Hematol; 2007 Dec; 64(3):234-46. PubMed ID: 17544290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic lymphocytic leukemia: novel prognostic factors and their relevance for risk-adapted therapeutic strategies.
    Montillo M; Hamblin T; Hallek M; Montserrat E; Morra E
    Haematologica; 2005 Mar; 90(3):391-9. PubMed ID: 15749671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and therapeutic implications of the mutational status of IgVH in patients with chronic lymphocytic leukemia.
    Kharfan-Dabaja MA; Chavez JC; Khorfan KA; Pinilla-Ibarz J
    Cancer; 2008 Sep; 113(5):897-906. PubMed ID: 18618518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in the diagnosis and treatment of chronic lymphocytic leukemia.
    Abbott BL
    Clin Adv Hematol Oncol; 2004 Jul; 2(7):448-54. PubMed ID: 16163221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controversies in the front-line management of chronic lymphocytic leukemia.
    Nabhan C; Shanafelt TD; Kay NE
    Leuk Res; 2008 May; 32(5):679-88. PubMed ID: 18191201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimal residual disease in chronic lymphocytic leukaemia: is it ready for primetime?
    Nabhan C; Coutré S; Hillmen P
    Br J Haematol; 2007 Feb; 136(3):379-92. PubMed ID: 17129223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic lymphocytic leukemia: recent advances in diagnosis and treatment.
    Abbott BL
    Oncologist; 2006 Jan; 11(1):21-30. PubMed ID: 16401710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current approach to diagnosis and management of chronic lymphocytic leukemia.
    Shanafelt TD; Call TG
    Mayo Clin Proc; 2004 Mar; 79(3):388-98. PubMed ID: 15008611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Richter syndrome: biology, incidence, and therapeutic strategies.
    Tsimberidou AM; Keating MJ
    Cancer; 2005 Jan; 103(2):216-28. PubMed ID: 15578683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caring for patients with chronic lymphocytic leukemia.
    Elphee EE
    Clin J Oncol Nurs; 2008 Jun; 12(3):417-23. PubMed ID: 18515240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging therapy for chronic lymphocytic leukaemia.
    Auer RL; Gribben J; Cotter FE
    Br J Haematol; 2007 Dec; 139(5):635-44. PubMed ID: 17961187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent progress in the management of chronic lymphocytic leukemia.
    Robak T
    Cancer Treat Rev; 2007 Dec; 33(8):710-28. PubMed ID: 17904294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathology of chronic lymphocytic leukemia: an update.
    Inamdar KV; Bueso-Ramos CE
    Ann Diagn Pathol; 2007 Oct; 11(5):363-89. PubMed ID: 17870025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimal residual disease assessment in chronic lymphocytic leukaemia.
    Sayala HA; Rawstron AC; Hillmen P
    Best Pract Res Clin Haematol; 2007 Sep; 20(3):499-512. PubMed ID: 17707836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of treatment strategies in chronic lymphocytic leukemia. Part 2 of a 3-Part series: Advances in the treatment of hematologic malignancies.
    Keating MJ; Rai KR; Wierda WG
    Clin Adv Hematol Oncol; 2005 Aug; 3(8):1-10; quiz 11-2. PubMed ID: 16201050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
    Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
    Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nursing guidelines for managing infections in patients with chronic lymphocytic leukemia.
    Moran M; Browning M; Buckby E
    Clin J Oncol Nurs; 2007 Dec; 11(6):914-24. PubMed ID: 18063549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.